LAURA
GOMEZ CUADRADO
![Foto de LAURA](/img/uploaded/84358F2066306855E1DBEE169427C5B6.jpg)
![Foto de AstraZeneca (United Kingdom)](/img/noimage_org.png)
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoAstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2016
-
Identification of novel pathways linking epithelial-to-mesenchymal transition with resistance to HER2-targeted therapy
Oncotarget, Vol. 7, Núm. 10, pp. 11539-11552
-
Use of a genetically engineered mouse model as a preclinical tool for HER2 breast cancer
DMM Disease Models and Mechanisms, Vol. 9, Núm. 2, pp. 131-140